← Back
$WVE All transactions

Wave Life Sciences Ltd.

▼ SELL 10b5-1 Plan

$ Value

$22K

Shares

1,295

Price

$17

Filed

Jan 6

Insider

Name

Francis Chris

Title

See Remarks

CIK

0001657709

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,000

Footnotes

The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025. | These share options are fully vested. | The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.56 to $16.54 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. | The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $16.61 to $16.79 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Filing Info

Accession No.

0001193125-26-005195

Form Type

4

Issuer CIK

0001631574

Francis Chris's History

Date Ticker Type Value
2026-02-26 WVE M $69K
2026-02-26 WVE $270K
2026-02-26 WVE M $73K
2026-02-26 WVE $229K
2026-02-26 WVE M $0
2026-02-26 WVE M $0
2026-02-09 WVE $25K
2026-02-05 WVE A $0
2026-02-05 WVE A $0
2026-01-02 WVE M $29K

Other Insiders at WVE (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $54.6M 2026-03-30
Vargeese Chandra
See Remarks
$43K 2026-02-09
Francis Chris
See Remarks
$525K 2026-02-26
BOLNO PAUL
President and CEO
$141K 2026-02-09
Moran Kyle
Chief Financial Officer
$48K 2026-02-09
TAKANASHI KEN 2026-03-23